Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor.
TH Open
; 5(2): e163-e165, 2021 Apr.
Article
in En
| MEDLINE
| ID: mdl-34007955
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Risk_factors_studies
Language:
En
Journal:
TH Open
Year:
2021
Document type:
Article
Affiliation country: